P.559 Comparison of possible safety risks on clinical trials between PP3M and PP1M
| Autor: | Watanabe, S., Masayoshi, T., Hirokazu, K., Ayako, S., Keiko, Y., Midori, T., Akihide, W., Akiko, F. |
|---|---|
| Zdroj: | In European Neuropsychopharmacology November 2020 40 Supplement 1:S317-S318 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect